A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans
Status:
COMPLETED
Trial end date:
2025-07-21
Target enrollment:
Participant gender:
Summary
This study aims to investigate the pharmacokinetics of bupivacaine liposomal injection (test preparation) in healthy subjects. The manufactured liposomal bupivacaine injection (EXPAREL) was used as the reference formulation to evaluate the human bioequivalence between the two formulations.